2397 Stock Overview
Develops DNA microarrays in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
DNA Chip Research Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥607.00 |
| 52 Week High | JP¥2,100.00 |
| 52 Week Low | JP¥599.00 |
| Beta | 0.79 |
| 1 Month Change | -13.29% |
| 3 Month Change | -23.16% |
| 1 Year Change | -10.60% |
| 3 Year Change | 31.67% |
| 5 Year Change | -13.90% |
| Change since IPO | -91.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2397 | JP Life Sciences | JP Market | |
|---|---|---|---|
| 7D | -7.5% | 0.6% | 0.5% |
| 1Y | -10.6% | -11.1% | 13.6% |
Return vs Industry: 2397 matched the JP Life Sciences industry which returned -11.1% over the past year.
Return vs Market: 2397 underperformed the JP Market which returned 13.6% over the past year.
Price Volatility
| 2397 volatility | |
|---|---|
| 2397 Average Weekly Movement | 4.6% |
| Life Sciences Industry Average Movement | 5.6% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 2397 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 2397's weekly volatility has decreased from 10% to 5% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 37 | Ryo Matoba | www.dna-chip.co.jp |
DNA Chip Research Inc. develops DNA microarrays in Japan. The company offers research and development, contract research, and diagnostic support services. It offers Tbone EX Kit for Japanese forensic laboratories in police force and universities.
DNA Chip Research Inc. Fundamentals Summary
| 2397 fundamental statistics | |
|---|---|
| Market cap | JP¥4.09b |
| Earnings (TTM) | -JP¥118.00m |
| Revenue (TTM) | JP¥766.00m |
5.4x
P/S Ratio-34.8x
P/E RatioIs 2397 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2397 income statement (TTM) | |
|---|---|
| Revenue | JP¥766.00m |
| Cost of Revenue | JP¥472.00m |
| Gross Profit | JP¥294.00m |
| Other Expenses | JP¥412.00m |
| Earnings | -JP¥118.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 04, 2025
| Earnings per share (EPS) | -17.44 |
| Gross Margin | 38.38% |
| Net Profit Margin | -15.40% |
| Debt/Equity Ratio | 0% |
How did 2397 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 11:07 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
DNA Chip Research Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|